2022
DOI: 10.21769/bioprotoc.4464
|View full text |Cite
|
Sign up to set email alerts
|

VirScan: High-throughput Profiling of Antiviral Antibody Epitopes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(16 citation statements)
references
References 18 publications
0
16
0
Order By: Relevance
“…Given the challenge of mapping antibody epitopes at high resolution, it has been unclear how common recurrent antibody responses are and how widely they are shared across human populations. Recently, we developed VirScan, a phage display platform programmed to display peptides spanning the human virome, which enabled the high-throughput identification of antiviral antibody epitopes (14)(15)(16)(17)(18). We used VirScan to profile hundreds of human serum samples (14) and found that although many viral peptides recognized by an individual were relatively specific to that person, many other viral peptides-which we termed "public epitopes"-were recognized by a substantial percentage (≤98%) of individuals seropositive for the given virus (14).…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Given the challenge of mapping antibody epitopes at high resolution, it has been unclear how common recurrent antibody responses are and how widely they are shared across human populations. Recently, we developed VirScan, a phage display platform programmed to display peptides spanning the human virome, which enabled the high-throughput identification of antiviral antibody epitopes (14)(15)(16)(17)(18). We used VirScan to profile hundreds of human serum samples (14) and found that although many viral peptides recognized by an individual were relatively specific to that person, many other viral peptides-which we termed "public epitopes"-were recognized by a substantial percentage (≤98%) of individuals seropositive for the given virus (14).…”
Section: Resultsmentioning
confidence: 99%
“…We performed VirScan ( 14 16 ), which is based on the phage immunoprecipitation and sequencing (PhIP-Seq) methodology ( 17 ), as described previously ( 14 16 , 18 ) or with slight modifications. For the light chain isotype-specific IPs, we substituted magnetic protein A and protein G Dynabeads (Invitrogen) with 5 μg of biotinylated goat anti-human kappa (Southern Biotech) or 4 μg of biotinylated goat anti-human lambda (Southern Biotech) antibodies.…”
Section: Methodsmentioning
confidence: 99%
See 3 more Smart Citations